Publications by authors named "Angelo Gousse"

Claim this Profile
C
Case report: Acute urinary retention due to sloughed tissue following prostate artery embolization.
Balaji N Reddy, Austin Freedman, Curtis Anderson, Angelo Gousse

Urol Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EDITORIAL COMMENT.
Angelo Etienne Gousse

Urology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation.
David A Ginsberg, Timothy B Boone, Anne P Cameron, Angelo Gousse, Melissa R Kaufman

J Urol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up.
David A Ginsberg, Timothy B Boone, Anne P Cameron, Angelo Gousse, Melissa R Kaufman

J Urol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Angelo E Gousse

J Urol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial.
Kurt McCammon, Angelo Gousse, Alfred Kohan, David Glazier, Jennifer Gruenenfelder

Female Pelvic Med Reconstr Surg· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior Vaginal Wall Prolapse Repair and the Rise and Fall of Transvaginal Mesh. Did We Come Full Circle? A Historical Perspective.
Kirin K Syed, Michael J Consolo, Angelo E Gousse

Urology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of urethral stricture disease in women: A multi-institutional collaborative project from the SUFU research network.
Giulia I Lane, Ariana L Smith, Hanna Stambakio, George Lin, Omar Al Hussein Alawamlh, Angelo Gousse

Neurourol Urodyn· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance and management of urologic complications after spinal cord injury.
Evgeniy Kreydin, Blayne Welk, Doreen Chung, Quentin Clemens, Claire Yang, Angelo Gousse

World J Urol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder.
David A Ginsberg, Marcus J Drake, Albert Kaufmann, Sidney Radomski, Angelo E Gousse

J Urol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Angelo E Gousse, Nicole M Szell

Urology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Angelo E Gousse

Urology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed urinary incontinence: what first?
Nazia Q Bandukwala, Angelo E Gousse

Curr Urol Rep· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.
David Ginsberg, Francisco Cruz, Sender Herschorn, Angelo Gousse, Véronique Keppenne

Adv Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.
Sender Herschorn, Jack Barkin, David Castro-Diaz, Jeffrey M Frankel, Montserrat Espuna-Pons, Angelo E Gousse

Urology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB.
Linda Brubaker, Angelo Gousse, Peter Sand, Catherine Thompson, Vaishali Patel

Int Urogynecol J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.
David Ginsberg, Angelo Gousse, Veronique Keppenne, Karl-Dietrich Sievert, Catherine Thompson

J Urol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.
Prashanth Kanagarajah, Rajinikanth Ayyathurai, Daniel J Caruso, Christopher Gomez, Angelo E Gousse

Int Urol Nephrol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder dysfunction in patients with diabetes.
Christopher S Gomez, Prashanth Kanagarajah, Angelo E Gousse

Curr Urol Rep· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voiding dysfunction in the female patient: is the "syndrome" paradigm valid?
Hari Siva G R Tunuguntla, Renuka Tunuguntla, Joseph Barone, Prashanth Kanagarajah, Angelo E Gousse

Curr Urol Rep· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat intradetrusor injections of onabotulinum toxin a for refractory idiopathic overactive bladder patients: a single-center experience.
Angelo E Gousse, Prashanth Kanagarajah, Rajinikanth Ayyathurai, Priyanka Handa, Nikita Dabas

Female Pelvic Med Reconstr Surg· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the predictive value of urodynamics to reproduce clinical findings of urinary frequency, urge urinary incontinence, and/or stress urinary incontinence?
Daniel J Caruso, Prashanth Kanagarajah, Brian L Cohen, Rajinikanth Ayyathurai, Christopher Gomez, Angelo E Gousse

Int Urogynecol J· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of botulinum toxin a in idiopathic overactive bladder syndrome.
Christopher S Gomez, Prashanth Kanagarajah, Angelo Gousse

Curr Urol Rep· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder.
Brian L Cohen, Daniel J Caruso, Prashanth Kanagarajah, Angelo E Gousse

Adv Urol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges of iatrogenic proximal ureteric reconstruction.
Daniel Caruso, Angelo E Gousse

Curr Urol Rep· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis